--- title: "Sinemet IR vs CR vs Rytary vs Inbrija: Carbidopa-Levodopa Formulations Compared" description: "All four are carbidopa-levodopa, but they release the drug at different speeds. Here is who each Parkinson's formulation is for and how they get layered together in real-world regimens." canonical_url: "https://parkinsonspathways.com/learn/carbidopa-levodopa-formulations-compared" date_published: 2026-05-12 date_modified: 2026-05-12 source: "Parkinson's Pathways" --- # Sinemet IR vs CR vs Rytary vs Inbrija: Carbidopa-Levodopa Formulations Compared Carbidopa-levodopa is the most prescribed medication for Parkinson's, but it comes in several different forms, and the differences matter a lot for how someone feels day to day. Sinemet IR, Sinemet CR, Rytary, and Inbrija are all carbidopa-levodopa, but they release the drug in different ways and at different speeds. Here is what each formulation is, who it is for, and the trade-offs. ## Why the Formulation Matters Levodopa is short-acting. A single immediate-release tablet starts working in about 30 to 60 minutes and wears off in three to four hours. As Parkinson's progresses, the brain becomes less able to smooth out those peaks and valleys, which leads to motor fluctuations: feeling great for a few hours, then suddenly slow, stiff, or tremulous until the next dose kicks in. Different formulations exist to either smooth out those swings or to rescue someone in the middle of a sudden OFF episode. ## Sinemet IR (Immediate Release) The original carbidopa-levodopa tablet. Available as 25/100, 25/250, and 10/100 (the first number is carbidopa milligrams, the second is levodopa milligrams). Onset is fast, around 30 to 60 minutes. Duration is short, around three to four hours. This is the workhorse. Most people start with IR, and many stay on it for years. It is the cheapest formulation, available as a generic, and the easiest to titrate up or down because the dose is well understood. The downside is that as the disease progresses, the short duration means more frequent dosing — sometimes every two to three hours through the day — and bigger swings between doses. ## Sinemet CR (Controlled Release) A controlled-release version that releases levodopa more slowly over four to six hours. Onset is slower than IR, often 60 to 90 minutes. Many people use CR at bedtime to cover the night without having to wake up for a midnight dose. CR rarely replaces IR completely during the day because the slower onset can leave people stuck in OFF time before it kicks in. Absorption is also less predictable than IR, especially around meals. ## Rytary (Extended-Release Capsules) Rytary is a capsule containing immediate-release and extended-release beads, designed to give a faster onset like IR plus a longer duration than CR. A single Rytary dose typically lasts five to six hours, which can mean three doses a day instead of five or six tablets of IR. The trade-off is dose conversion. Rytary is not a one-to-one swap with IR. The levodopa numbers on the capsule are not directly comparable, so switching requires a careful titration with your neurologist. It is also significantly more expensive than generic IR, and insurance coverage varies. For people whose lives are disrupted by frequent dosing or unpredictable wearing off, Rytary often improves daily quality of life noticeably. ## Inbrija (Inhaled Levodopa) Inbrija is levodopa as a dry-powder inhaler. It is not a maintenance medication. It is a rescue treatment for OFF episodes that come on between scheduled doses. Onset is around 10 minutes, much faster than any swallowed pill. People typically use Inbrija up to five times a day, alongside their regular oral carbidopa-levodopa. The cartridges are taken with a special inhaler, and it takes some practice. Cost and insurance coverage are real considerations. ## A Word on Vyalev (Continuous Subcutaneous Levodopa) Vyalev (foslevodopa-foscarbidopa) is a newer continuous infusion delivered under the skin through a small pump worn 24 hours a day. It is FDA approved for advanced Parkinson's with motor fluctuations and is an alternative to Duopa for people who want to avoid the surgical tube. Our article on [DBS vs Duopa vs focused ultrasound](/learn/dbs-vs-duopa-vs-focused-ultrasound-parkinsons) covers continuous-infusion options in more detail. ## A Side by Side Look - **Sinemet IR.** Fast onset, short duration, cheap, most flexible. The default. - **Sinemet CR.** Slow onset, medium duration, useful at bedtime. Rarely a full daytime replacement. - **Rytary.** IR-like onset with longer duration. Fewer daily doses. Expensive. Requires careful conversion. - **Inbrija.** Inhaled rescue for sudden OFF episodes. Not a maintenance drug. Very fast onset. - **Vyalev.** Continuous 24-hour infusion under the skin. For advanced Parkinson's with significant fluctuations. ## How These Get Layered Together A typical advanced regimen is not a single formulation. It is often Rytary or IR through the day, sometimes CR at bedtime, and Inbrija on hand for breakthrough OFF episodes. The right combination depends on how the person's day is shaped, which symptoms are most disabling, and what insurance covers. ## What Trials Are Studying Right Now Active trials are testing new long-acting carbidopa-levodopa formulations, continuous infusion improvements, and add-on drugs that extend the effect of each levodopa dose. Browse [levodopa trials](/trials?q=levodopa) directly with keyword search. ## The Conversation Worth Having The right formulation is rarely the one a primary-care doctor or general neurologist defaults to. A movement disorders specialist sees these combinations every day and can usually fine-tune a regimen in one or two visits. If your medication is no longer giving smooth coverage, that is the conversation to ask for. See also our piece on [levodopa vs dopamine agonists](/learn/levodopa-vs-dopamine-agonists) for how the broader medication classes fit together. ## Frequently Asked Questions ### Why isn't there a once-a-day Parkinson's pill? Levodopa is short-acting by nature. The brain needs a steady supply, and the digestive system absorbs it in pulses, which makes a true once-daily oral dose impractical. Continuous infusion devices like Vyalev and Duopa are the closest thing to a steady supply. ### Can I split a Rytary capsule? No. Rytary capsules contain extended-release beads that depend on intact capsule structure to release at the right rate. Splitting or crushing changes the absorption and can cause sudden peaks or sudden OFF time. They can be opened and sprinkled on applesauce if swallowing is difficult. ### Is Sinemet CR the same as Rytary? No. Both are extended-release, but they release levodopa differently. Sinemet CR has slow onset and lasts four to six hours. Rytary has a faster onset closer to immediate-release plus a longer tail. The two are not interchangeable on a milligram basis. ### Why does my levodopa work less well around meals? Levodopa competes with dietary protein for absorption in the small intestine. A high-protein meal taken with a dose can blunt how much reaches the brain. Many people take levodopa 30 minutes before meals or shift protein to dinner to keep daytime doses working better. ### Is generic carbidopa-levodopa as good as brand-name Sinemet? Yes. Generic carbidopa-levodopa is FDA-equivalent to Sinemet IR and is what most people take. Some people report that switching between manufacturers changes how a dose feels, so if generic worked well from one pharmacy, it is reasonable to ask the pharmacy to keep using the same supplier. --- *Canonical: https://parkinsonspathways.com/learn/carbidopa-levodopa-formulations-compared* *HTML version: https://parkinsonspathways.com/learn/carbidopa-levodopa-formulations-compared*